Back to User profile » Dr Jing Li
Paper published by Dr Jing Li:
Original Research
Nivolumab-AVD versus Brentuximab Vedotin-AVD as First-Line Treatment for Advanced-Stage Classical Hodgkin Lymphoma: A Cost-Effectiveness Analysis
Li B, Yang J, Li J, Huang J, Li Z
ClinicoEconomics and Outcomes Research 2026, 18:590836
Published Date: 19 May 2026